Cancer in the Arab World.

• Author: Al-Shamsi, Humaid O.
• TeilnehmendeR: Abu-Gheida, Ibrahim H.; Iqbal, Faryal.; Al-Awadhi, Aydah.
• Place / Publishing House: Singapore : : Springer Singapore Pte. Limited,, 2022.; ©2022.
• Year of Publication: 2022
• Edition: 1st ed.
• Language: English
• Physical Description: 1 online resource (479 pages)

Table of Contents

• Intro
• Acknowledgment
• Contents
• About the Editors
• Chapter 1: Introduction
• 1.1 Background
• 1.2 Cancer Profile in the Arab World: An Overview
• 1.3 Cancer Risk Factors
• 1.4 Current Circumstantial Analysis
• 1.5 Oncology Care in the Arab World
• 1.5.1 Role of Cancer Registries
• 1.5.2 Functionality of Oncology Societies in the Arab Region
• 1.6 Cancer Control Framework Recommendations
• 1.7 Cancer in the Arab World Book
• 1.7.1 Book Structure
• 1.8 Closing the Gaps in the Cancer Care System
• 1.9 Concluding Remarks
• References
• Chapter 2: General Oncology Care in Algeria
• 2.1 Algeria Demographics
• 2.2 Cancer Statistics in Algeria
• 2.2.1 Cancer Incidence in Algeria
• 2.3 Oncology Care in Algeria
• 2.3.1 National Cancer Control Plan 2015-2019
• 2.4 Cancer Risk Factors
• 2.5 Cancer Screening Programs
• 2.5.1 Cervical Cancer
• 2.5.2 Breast Cancer
• 2.5.3 Colorectal Cancer
• 2.5.4 Prostate Cancer
• 2.6 Cancer Prevention Programs
• 2.7 Cancer Diagnosis
• 2.8 Treatment
• 2.8.1 Medical Oncology
• 2.8.2 Radiation Therapy
• 2.8.3 Surgery
• 2.8.4 Pediatric Oncology
• 2.8.5 Survivorship Track
• 2.8.6 Palliative Care Track
• 2.9 Research and Education
• 2.9.1 Clinical Trials and Research
• 2.9.2 Scientific Publications
• 2.9.3 Training and Education
• 2.9.4 Paramedical Training
• 2.10 Cost Effective Cancer Care
• 2.11 Challenges and Advantages
• 2.11.1 Access to Innovative Treatments
• 2.11.2 Cancer Care
• 2.12 The Future of Cancer Care in Algeria
• 2.13 Conclusion
• References
• Chapter 3: General Oncology Care in Bahrain
• 3.1 Bahrain Demographics
• 3.2 Cancer Statistics in Bahrain
• 3.3 Oncology Care in Bahrain
• 3.4 Cancer Risk Factors
• 3.5 Cancer Screening Programs
• 3.6 Cancer Prevention Programs
• 3.7 Cancer Diagnosis
• 3.8 Treatment
• 3.8.1 Medical Oncology.
• 3.8.2 Radiation Therapy
• 3.8.3 Surgery
• 3.8.4 Pediatric Oncology
• 3.8.5 Survivorship Track
• 3.8.6 Palliative Care Track
• 3.9 Research and Education
• 3.9.1 National Tumor Board (NTB)
• 3.10 Cost-Effective Cancer Care
• 3.11 Challenges and Advantages
• 3.12 The Future of Cancer Care in Bahrain
• 3.13 Conclusion
• References
• Chapter 4: General Oncology Care in Egypt
• 4.1 Egypt Demographics
• 4.1.1 Population
• 4.1.2 Regions
• 4.1.3 Economy
• 4.1.4 Government
• 4.1.5 Life Expectancy
• 4.2 Cancer Statistics in Egypt
• 4.3 Oncology Care in Egypt
• 4.3.1 Liver Cancer
• 4.3.2 Breast Cancer
• 4.3.3 Bladder Cancer
• 4.4 Cancer Risk Factors
• 4.4.1 Liver Cancer
• 4.4.2 Bladder Cancer
• 4.5 Cancer Screening Programs
• 4.6 Cancer Prevention Programs
• 4.6.1 Anti-Schistosomiasis Campaigns
• 4.6.2 Anti-HCV and HBV Campaigns
• 4.7 Cancer Diagnosis
• 4.7.1 Imaging
• 4.7.2 Molecular Testing
• 4.7.3 Cytogenetics and Genetic Testing
• 4.8 Treatment
• 4.8.1 Medical Oncology
• 4.8.2 Radiation Therapy
• 4.8.3 Surgery
• 4.8.4 Pediatric Oncology
• 4.8.5 Survivorship Track
• 4.8.6 Palliative Care Track
• 4.9 Research and Education
• 4.10 Cost-Effective Cancer Care
• 4.11 Challenges and Advantages
• 4.12 The Future of Cancer Care in Egypt
• 4.13 Conclusion
• References
• Chapter 5: General Oncology Care in Iraq
• 5.1 Iraq Demographics
• 5.2 Cancer Statistics in Iraq
• 5.3 Healthcare System in Iraq
• 5.4 Oncology Care in Iraq
• 5.5 Cancer Risk Factors
• 5.6 Cancer Screening Programs
• 5.7 Cancer Prevention Programs
• 5.8 Cancer Diagnosis
• 5.8.1 Imaging
• 5.8.2 Laboratory
• 5.8.3 Cytogenetic and Molecular Genetics
• 5.9 Treatment
• 5.9.1 Medical and Radiation Oncology
• 5.9.2 Medical Oncology
• 5.9.2.1 Hematopoietic Stem Cell Transplantation
• 5.9.3 Radiation Therapy
• 5.9.4 Surgery.
• 5.9.5 Pediatric Oncology
• 5.9.6 Survivorship Track
• 5.9.7 Palliative Care Track
• 5.10 Research and Education
• 5.10.1 Research
• 5.10.1.1 The Iraqi Regional Comparative Breast Cancer Research Project
• 5.10.2 Education and Training
• 5.10.2.1 Local Education and Training
• 5.10.2.2 International Collaborations and Country Program Frameworks
• 5.11 Cost-Effective Cancer Care
• 5.12 Challenges and Advantages
• 5.13 The Future of Cancer Care in Iraq
• 5.14 Conclusion
• References
• Chapter 6: General Oncology Care in Jordan
• 6.1 Jordan Demographics
• 6.2 Cancer Statistics in Jordan
• 6.3 Healthcare System in Jordan
• 6.4 Oncology Care in Jordan
• 6.5 Cancer Risk Factors
• 6.6 Cancer Screening Programs
• 6.7 Cancer Prevention Programs
• 6.8 Cancer Diagnosis
• 6.9 Treatment
• 6.9.1 Medical Oncology
• 6.9.2 Radiation Therapy
• 6.9.3 Surgery
• 6.9.4 Pediatric Oncology
• 6.9.5 Survivorship Track
• 6.9.6 Palliative Care Track
• 6.10 Research and Education
• 6.11 Cost-Effective Cancer Care
• 6.12 Challenges and Advantages
• 6.12.1 Medical Tourism in Jordan
• 6.13 The Future of Cancer Care in Jordan
• 6.14 Conclusion
• References
• Chapter 7: General Oncology Care in Kuwait
• 7.1 Kuwait Demographics
• 7.2 Cancer Statistics in Kuwait
• 7.3 Cancer Risk Factors
• 7.3.1 Part 1: Ubiquitous Risk Factors: Where Does Kuwait Stand?
• 7.3.2 Part 2: Other Kuwait-Specific Risk Factors
• 7.4 Cancer Screening Programs
• 7.5 Cancer Prevention Programs
• 7.6 Cancer Diagnosis
• 7.6.1 Specialized Laboratory Services
• 7.7 Treatment
• 7.7.1 Medical Oncology
• 7.7.1.1 Malignant Hematology and Bone Marrow Transplantation (BMT)
• 7.7.2 Radiation Therapy
• 7.7.3 Surgery
• 7.7.4 Pediatric Oncology
• 7.7.5 Survivorship Track
• 7.7.6 Palliative Care Track
• 7.8 Research and Education
• 7.9 Challenges and Advantages.
• 7.10 The Future of Cancer Care in Kuwait
• 7.11 Conclusion
• References
• Chapter 8: General Oncology Care in Lebanon
• 8.1 Lebanon Demography
• 8.2 Cancer Statistics in Lebanon
• 8.3 Healthcare System in Lebanon
• 8.4 Oncology Care in Lebanon
• 8.5 Cancer Risk Factors
• 8.6 Cancer Screening Programs
• 8.7 Cancer Prevention Programs
• 8.8 Cancer Diagnosis
• 8.8.1 Imaging
• 8.8.2 Laboratory
• 8.8.3 Cytogenetics and Medical Genetics
• 8.8.4 Molecular Diagnostics
• 8.9 Treatment
• 8.9.1 Medical Oncology
• 8.9.2 Radiation Therapy
• 8.9.3 Surgery
• 8.9.4 Pediatric Oncology
• 8.9.5 Survivorship Track
• 8.9.6 Palliative Care Track
• 8.10 Research and Education
• 8.11 Cost-Effective Cancer Care
• 8.12 Challenges and Advantages
• 8.12.1 Facilities Providing Cancer Care
• 8.12.2 Treatment Availability
• 8.13 The Future of Cancer Care in Lebanon
• 8.14 Conclusion
• References
• Chapter 9: General Oncology Care in Libya
• 9.1 Libya Demographics
• 9.2 Cancer Statistics in Libya
• 9.3 Healthcare System in Libya
• 9.4 Oncology Care in Libya
• 9.5 Cancer Risk Factors
• 9.6 Cancer Screening Programs
• 9.7 Cancer Prevention Programs
• 9.8 Cancer Diagnosis
• 9.8.1 Imaging
• 9.8.2 Laboratory
• 9.9 Treatment
• 9.9.1 Medical Oncology
• 9.9.1.1 Advanced Treatments
• 9.9.1.2 Bone Marrow Transplantation
• 9.9.2 Radiation Therapy
• 9.9.3 Surgery
• 9.9.4 Pediatric Oncology
• 9.9.5 Survivorship Track
• 9.9.6 Palliative Care Track
• 9.10 Research and Education
• 9.10.1 Research
• 9.10.2 Education and Training
• 9.11 Cost-Effective Cancer Care
• 9.12 Challenges and Advantages
• 9.12.1 Medical Tourism in Libya
• 9.13 The Future of Cancer Care in Libya
• 9.14 Conclusion
• References
• Chapter 10: General Oncology Care in Mauritania
• 10.1 Mauritania Demographics
• 10.2 Cancer Statistics in Mauritania.
• 10.3 Healthcare System in Mauritania
• 10.4 Oncology Care in Mauritania
• 10.5 Cancer Risk Factors
• 10.6 Cancer Screening Programs
• 10.7 Cancer Prevention Programs
• 10.8 Cancer Diagnosis
• 10.9 Treatment
• 10.9.1 Medical Oncology
• 10.9.2 Radiation Therapy
• 10.9.3 Surgery
• 10.9.4 Pediatric Oncology
• 10.9.5 Survivorship Track
• 10.9.6 Palliative Care Track
• 10.10 Research and Education
• 10.11 Cost-Effective Cancer Care
• 10.12 Challenges and Advantages
• 10.13 The Future of Cancer Care in Mauritania
• 10.14 Conclusion
• References
• Chapter 11: General Oncology Care in Morocco
• 11.1 Morocco Demographics
• 11.2 Cancer Statistics in Morocco
• 11.3 Cancer Risk Factors
• 11.3.1 Tobacco
• 11.3.2 Alcohol
• 11.3.3 Obesity
• 11.3.4 Other Risk Factors
• 11.4 Cancer Screening Programs
• 11.5 Cancer Prevention Programs
• 11.6 Cancer Diagnosis
• 11.7 Treatment
• 11.7.1 Medical Oncology
• 11.7.2 Radiation Therapy
• 11.7.3 Surgery
• 11.7.4 Pediatric Oncology
• 11.7.5 Survivorship Track
• 11.7.6 Palliative Care Track
• 11.8 Research and Education
• 11.8.1 Research
• 11.8.2 Education
• 11.9 Cost-Effective Cancer Care
• 11.10 Challenges and Advantages
• 11.11 The Future of Cancer Care in Morocco
• 11.11.1 Quality Improvement
• 11.11.2 Information Systems
• 11.12 Conclusion
• References
• Chapter 12: General Oncology Care in Oman
• 12.1 Oman Demographics
• 12.2 Cancer Statistics in Oman
• 12.3 Healthcare System in Oman
• 12.4 Oncology Care in Oman
• 12.4.1 Access to Cancer Care services
• 12.4.2 Multi-sectoral Efforts to Prevent and Control Cancer
• 12.4.3 National Oncology Center: The Royal Hospital
• 12.4.4 Other Cancer Centers
• 12.4.5 National Cancer Registry
• 12.4.6 Community Obligations
• 12.4.7 The Cancer Care Plan
• 12.5 Cancer Risk Factors
• 12.6 Cancer Screening Programs.
• 12.7 Cancer Prevention Programs.